

Please try another search
Cardiff Oncology, Inc. (Nasdaq: CRDF) today announced that the first patient was dosed this month with its investigational drug onvansertib in its Phase 2 ONSEMBLE trial (NCT05593328). The trial is...
Investing.com - Cardiff Oncology (NASDAQ: CRDF) reported first quarter EPS of $-0.220, $0.02 better than the analyst estimate of $-0.235. Revenue for the quarter came in at $96.5K versus the consensus...
Pre-Open Stock Movers: Antares Pharma, Inc. (NASDAQ:ATRS) 49% HIGHER; Halozyme Therapeutics, Inc. (NASDAQ:HALO) agreed to acquire the company for $5.60 per share in cash, or $960 million. Sierra...
After-Hours Stock Movers: NanoString Technologies Inc (NASDAQ:NSTG) 29% LOWER; announced preliminary total product and service revenue of approximately $31 million for the first quarter, versus prior...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Financials, Technology and Consumer Goods sectors led shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Oil & Gas, Basic Materials and Industrials sectors led shares lower. At the close in NYSE, the Dow Jones Industrial...
Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Basic Materials, Oil & Gas and Financials sectors led shares lower. At the close in NYSE, the Dow Jones Industrial...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review